Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

RxSight (RXST) Long-Term Debt Issuances (2020 - 2021)

RxSight (RXST) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $10.0 million as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million, compared with a TTM value of $10.0 million through Sep 2022, down 75.0%, and an annual FY2023 reading of $20.0 million, changed N/A over the prior year.
  • Long-Term Debt Issuances was $10.0 million for Q2 2021 at RxSight, up from $5.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $25.0 million in Q4 2020 and bottomed at $5.0 million in Q1 2021.